5 research outputs found
Π¦ΠΈΡΠΎΠΊΡΠ½ΠΎΠ²ΠΈΠΉ ΠΏΡΠΎΡΡΠ»Ρ Ρ Π²Π°Π³ΡΡΠ½ΠΈΡ Π· Ρ Π»Π°ΠΌΡΠ΄ΡΠΉΠ½ΠΎ-Π²ΡΡΡΡΠ½ΠΎΡ ΡΠ½ΡΠ΅ΠΊΡΡΡΡ
Π£ΡΠΎΠ³Π΅Π½ΠΈΡΠ°Π»ΡΠ½ΡΠΉ Ρ
Π»Π°ΠΌΠΈΠ΄ΠΈΠΎΠ· ΠΈ Π²ΠΈΡΡΡΠ½Π°Ρ ΠΈΠ½ΡΠ΅ΠΊΡΠΈΡ β ΡΡΠΎ Π°ΠΊΡΡΠ°Π»ΡΠ½Π°Ρ ΠΌΠ΅Π΄ΠΈΠΊΠΎ-ΡΠΎΡΠΈΠ°Π»ΡΠ½Π°Ρ ΠΏΡΠΎΠ±Π»Π΅ΠΌΠ°, ΠΏΠΎΡΡΠΎΠΌΡ
ΡΠ³Π»ΡΠ±Π»Π΅Π½Π½ΡΠ΅ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΈΡ
, ΠΈΠΌΠΌΡΠ½ΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΡ
ΠΈ ΡΠ½Π΄ΠΎΠΊΡΠΈΠ½ΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΡ
Π°ΡΠΏΠ΅ΠΊΡΠΎΠ² ΡΡΠΎΠΉ ΠΏΡΠΎΠ±Π»Π΅ΠΌΡ Ρ
Π±Π΅ΡΠ΅ΠΌΠ΅Π½Π½ΡΡ
, ΡΠ°Π·ΡΠ°Π±ΠΎΡΠΊΠ° ΠΈ Π²Π½Π΅Π΄ΡΠ΅Π½ΠΈΠ΅ Π»Π΅ΡΠ΅Π±Π½ΠΎ-ΠΏΡΠΎΡΠΈΠ»Π°ΠΊΡΠΈΡΠ΅ΡΠΊΠΈΡ
ΠΏΡΠΎΠ³ΡΠ°ΠΌΠΌ ΡΠ²Π»ΡΠ΅ΡΡΡ ΠΎΠ΄Π½ΠΈΠΌ ΠΈΠ· ΠΏΠ΅ΡΡΠΏΠ΅ΠΊΡΠΈΠ²Π½ΡΡ
ΡΠ΅Π·Π΅ΡΠ²ΠΎΠ² ΡΠ½ΠΈΠΆΠ΅Π½ΠΈΡ ΡΠ΅ΠΏΡΠΎΠ΄ΡΠΊΡΠΈΠ²Π½ΡΡ
ΠΏΠΎΡΠ΅ΡΡ, ΠΌΠ°ΡΠ΅ΡΠΈΠ½ΡΠΊΠΎΠΉ ΠΈ ΠΏΠ΅ΡΠΈΠ½Π°ΡΠ°Π»ΡΠ½ΠΎΠΉ Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π΅ΠΌΠΎΡΡΠΈ. ΠΠΌΠ΅ΡΡΠ΅ Ρ ΡΡΠΈΠΌ,
ΡΠ°ΠΊΠΈΠ΅ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ ΡΠΎΡΡΠ°Π²Π»ΡΡΡ Π·Π½Π°ΡΠΈΡΠ΅Π»ΡΠ½ΡΠΉ Π½Π°ΡΡΠ½ΡΠΉ ΠΈΠ½ΡΠ΅ΡΠ΅Ρ ΠΈ Π±ΠΎΠ»ΡΡΡΡ ΠΏΡΠ°ΠΊΡΠΈΡΠ΅ΡΠΊΡΡ ΡΠ΅Π½Π½ΠΎΡΡΡ.
ΠΡΠΈ ΠΈΠ·ΡΡΠ΅Π½ΠΈΠΈ ΠΌΠ΅Ρ
Π°Π½ΠΈΠ·ΠΌΠΎΠ² ΠΎΡΠ»ΠΎΠΆΠ½Π΅Π½ΠΈΠΉ Π±Π΅ΡΠ΅ΠΌΠ΅Π½Π½ΠΎΡΡΠΈ Π±ΠΎΠ»ΡΡΠΎΠΉ ΠΈΠ½ΡΠ΅ΡΠ΅Ρ Π²ΡΠ·ΡΠ²Π°ΡΡ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ
ΡΡΠ½ΠΊΡΠΈΠΎΠ½Π°Π»ΡΠ½ΠΎΠ³ΠΎ ΡΠΎΡΡΠΎΡΠ½ΠΈΡ ΠΊΠ»Π΅ΡΠΎΠΊ ΠΠΠ‘ (ΠΏΡΡΠ΅ΠΌ ΠΎΠΏΡΠ΅Π΄Π΅Π»Π΅Π½ΠΈΡ ΡΡΠΎΠ²Π½Ρ ΠΏΡΠΎΠ²ΠΎΡΠΏΠ°Π»ΠΈΡΠ΅Π»ΡΠ½ΡΡ
ΡΠΈΡΠΎΠΊΠΈΠ½ΠΎΠ² ΠΠ -
1Ξ², Π€ΠΠ -Ξ±), Π° ΡΠ°ΠΊΠΆΠ΅ Π’-Π»ΠΈΠΌΡΠΎΡΠΈΡΠΎΠ² (ΠΏΡΡΠ΅ΠΌ ΠΎΠΏΡΠ΅Π΄Π΅Π»Π΅Π½ΠΈΡ ΠΏΡΠΎΠ²ΠΎΡΠΏΠ°Π»ΠΈΡΠ΅Π»ΡΠ½ΡΡ
ΡΠΈΡΠΎΠΊΠΈΠ½ΠΎΠ² ΠΠ -2, ΠΠ€Π-Ξ³ ΠΈ
ΠΏΡΠΎΠ²ΠΎΡΠΏΠ°Π»ΠΈΡΠ΅Π»ΡΠ½ΡΡ
ΡΠΈΡΠΎΠΊΠΈΠ½ΠΎΠ² ΠΠ -4, ΠΠ -10).Urogenital chlamydia and viral infection are actual medical and social problems. That is why the most promising reserves
to reduce reproductive losses, maternal and perinatal morbidity are deep study of clinical, immunological, microbiological
and endocrinological aspects of this problem among pregnant women, as well as developing and implementing of health
care programs. Moreover, such studies have significant scientific interest and great practical value.
While studying the mechanisms of pregnancy complications, the most interesting are the study of the functional
state of MMS cells (by determining the level of proinflammatory cytokines IL-1Ξ² TNF-Ξ±), and T-lymphocytes (by
determining the level of proinflammatory cytokines IL-2, IFN-Ξ³ and anti-inflammatory cytokines IL-4, IL-10)
Do Foley Catheters Adequately Drain the Bladder? Evidence from CT Imaging Studies
<title>ABSTRACT</title><sec><title>Introduction:</title><p>The Foley catheter has been widely assumed to be an effective means of draining the bladder. However, recent studies have brought into question its efficacy. The objective of our study is to further assess the adequacy of Foley catheter for complete drainage of the bladder.</p></sec><sec><title>Materials and Methods:</title><p>Consecutive catheterized patients were identified from a retrospective review of contrast enhanced and non-contrast enhanced computed tomo-graphic (CT) abdomen and pelvis studies completed from 7/1/2011-6/30/2012. Residual urine volume (RUV) was measured using 5mm axial CT sections as follows: The length (L) and width (W) of the bladder in the section with the greatest cross sectional area was combined with bladder height (H) as determined by multiplanar reformatted images in order to calculate RUV by applying the formula for the volume (V) of a sphere in a cube: V=(Ο/6)*(L*W*H).</p></sec><sec><title>Results:</title><p>RUVs of 167 (mean age 67) consecutively catheterized men (n=72) and women (n=95) identified by CT abdomen and pelvis studies were calculated. The mean RUV was 13.2 mL (range: 0.0 mL-859.1 mL, standard deviation: 75.9 mL, margin of error at 95% confidence:11.6 mL). Four (2.4%) catheterized patients had RUVs of >50 mL, two of whom had an improperly placed catheter tip noted on their CT-reports.</p></sec><sec><title>Conclusions:</title><p>Previous studies have shown that up to 43% of catheterized patients had a RUV greater than 50 mL, suggesting inadequacy of bladder drainage via the Foley catheter. Our study indicated that the vast majority of patients with Foley catheters (97.6%), had adequately drained bladders with volumes of <50 mL.</p></sec